Violation Tracker Parent Company Summary

Parent Company Name: 
Endo International
Ownership Structure: 
publicly traded (ticker symbol ENDP)
Headquartered in: 
Ireland (reincorporated for tax reasons)
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$477,856,417
Number of records: 
19
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$237,700,0004
False Claims Act and related$197,880,66710
drug or medical equipment safety violation$39,200,0002
price-fixing or anti-competitive practices$2,300,0001
consumer protection violation$760,0001
environmental violation$15,7501
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

Dava Pharmaceuticals, Inc.; Endo Health Solution; ENDO HEALTH SOLUTIONS; Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.; Endo International plc; Endo Pharmaceuticals; ENDO PHARMACEUTICALS AND VINTAGE PHARMACEUTICALS D/B/A QUALITEST PHARMACEUTICALS; Par Pharmaceutical Cos., Inc.; Par Pharmaceutical, Inc.; Par Pharmaceuticals, Inc.; PAR STERILE PRODUCTS LLC

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Endo Health Solutions Inc. off-label or unapproved promotion of medical products 2014 FDA $192,700,000
Endo Health Solution off-label or unapproved promotion of medical products 2014 MULTI-AG (*) $173,000,000
Par Pharmaceuticals, Inc. False Claims Act and related 2011 MULTI-AG $154,000,000
Par Pharmaceutical Companies Inc. off-label or unapproved promotion of medical products 2013 FDA $45,000,000
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals drug or medical equipment safety violation 2015 USAO $39,000,000
Endo Health Solutions False Claims Act and related 2015 MULTI-AG (*) $39,000,000
Par Pharmaceutical Companies Inc. off-label or unapproved promotion of medical products 2013 MULTI-AG (*) $22,500,000
Endo Pharmaceuticals False Claims Act and related 2013 TX-AG $18,170,000
Dava Pharmaceuticals Inc. False Claims Act and related 2012 DOJ_CIVIL $11,000,000
Dava Pharmaceuticals, Inc. False Claims Act and related 2012 MULTI-AG (*) $11,000,000
Par Pharmaceutical False Claims Act and related 2013 LA-AG $6,000,000
Par Pharmaceutical Inc. False Claims Act and related 2011 KY-AG $4,500,000
Endo International plc price-fixing or anti-competitive practices 2019 MULTI-AG $2,300,000
Par Pharmaceutical Co. False Claims Act and related 2011 MS-AG $2,010,667
Par Pharmaceutical Cos., Inc. False Claims Act and related 2011 ID-AG $1,700,000
Endo Pharmaceuticals consumer protection violation 2019 CA-AG $760,000
Par Pharmaceutical, Inc. False Claims Act and related 2010 MA-AG $500,000
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. drug or medical equipment safety violation 2016 NY-AG $200,000
PAR STERILE PRODUCTS LLC environmental violation 2002 EPA $15,750
Download results as CSV or XML